An Open-label, Cross Over Study, to Assess the Interactions of Pantoprazole (Proton Pump Inhibitor) With Oral Cladribine Administered in Subjects With Multiple Sclerosis.

Trial Profile

An Open-label, Cross Over Study, to Assess the Interactions of Pantoprazole (Proton Pump Inhibitor) With Oral Cladribine Administered in Subjects With Multiple Sclerosis.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2016

At a glance

  • Drugs Cladribine; Pantoprazole
  • Indications Multiple sclerosis
  • Focus Pharmacokinetics
  • Sponsors EMD Serono
  • Most Recent Events

    • 10 Jan 2012 Primary endpoints identified as reported by ClinicalTrials.gov.
    • 21 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top